Hosted on MSN23h
Top Analysts' Picks for 2025: 3 of Morgan Stanley's Favorites
Among sell-side analysts on Wall Street, Morgan Stanley is one of the most well-known. The company’s large investment banking ...
Nasdaq12d
This Is What Whales Are Betting On Morgan Stanley
Whales with a lot of money to spend have taken a noticeably bearish stance on Morgan Stanley. Looking at options history for Morgan Stanley (NYSE:MS) we detected 24 trades. If we consider the ...
Broadcom (NASDAQ:AVGO) Stock Price Down 0.8% Following Analyst Downgrade
Broadcom Inc. (NASDAQ:AVGO – Get Free Report) fell 0.8% during mid-day trading on Tuesday after Morgan Stanley lowered their price target on the stock from $265.00 to $246.00. Morgan Stanley currently ...
Intellia downgraded at Morgan Stanley on lowered expectations for rare disease asset
Morgan Stanley has downgraded Intellia Therapeutics (NASDAQ:NTLA) to equal weight from overweight citing "a more measured launch" of its transthyretin amyloidosis (ATTR) candidate nexiguran ziclumeran ...
Nasdaq10d
Investors Heavily Search Morgan Stanley (MS): Here is What You Need to Know
Morgan Stanley (MS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...
Morgan Stanley maintains $200 target on Sarepta Therapeutics stock
Morgan Stanley (NYSE:MS) reaffirmed its Overweight rating on Sarepta Therapeutics (NASDAQ:SRPT), an $11.27 billion market cap biotechnology company, with a steady price target of $200.00. The ...